HeartSciences Inc. (HSCS)

Market Cap	2.88M
Revenue (ttm)	18,600
Net Income (ttm)	-7.29M
Shares Out	913.32K
EPS (ttm)	-13.99
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,186
Open	3.280
Previous Close	3.280
Day's Range	2.950 - 3.400
52-Week Range	2.360 - 24.400
Beta	3.25
Analysts	Strong Buy
Price Target	15.00 (+376.19%)
Earnings Date	Dec 12, 2024

About HSCS

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility. It is developing artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction and conventional ECG information in the same test; and MyoVista Insights, a...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 15, 2022
• Employees: 15
• Stock Exchange: NASDAQ
• Ticker Symbol: HSCS
• Website: https://heartsciences.com

Financial Performance

In 2024, HeartSciences's revenue was $18,600, an increase of 261.17% compared to the previous year's $5,150. Losses were -$6.61 million, 3.95% more than in 2023.

Analyst Forecast

According to one analyst, the rating for HSCS stock is "Strong Buy" and the 12-month stock price forecast is $15.0.

Price Target

$15.0

(376.19% upside)

Analyst Consensus: Strong Buy